Diabetes is a risk factor for pulmonary tuberculosis: A Case-Control study from Mwanza, Tanzania

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Faurholt Jepsen, Daniel ^a   Range, Nyagosya ^b   PrayGod, George ^b   Jeremiah, Kidola ^b   Faurholt Jepsen, Maria ^a   Aabye, Martine Grosos ^a   Changalucha, John ^b   Christensen, Dirk Lund ^a,c   Pipper, Christian Bressen ^a   Krarup, Henrik ^d   Witte, Daniel Rinse ^c   Andersen, Aase Bengaard ^e   Friis, Henrik ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^c STENO DIABETES CENTER   (Denmark)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; GLUCOSE; OROSOMUCOID;

ACUTE PHASE RESPONSE; ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGLYCEMIA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; TANZANIA; ADOLESCENT; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; PATHOGENICITY; VIROLOGY;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; FEMALE; HIV-1; HIV-2; HUMANS; MALE; RISK FACTORS; TANZANIA; TUBERCULOSIS, PULMONARY;

EID: 80052302585     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024215     Document Type: Article

References (34)

1. Wild S, Roglic G, Green A, Sicree R, King H, (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-53 doi:15111519.
2. Diabetes Atlas (2009) 4th ed. IDF. p. 12 4th edition Available: www.idf.org. Accessed 2011 Aug.
3. King H, Aubert RE, Herman WH, (1998) Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21: 1414-1431 doi:10.2337/diacare.21.9.1414.
4. Kolling M, Winkley K, von Deden M, (2010) "For someone who's rich, it's not a problem". Insights from Tanzania on diabetes health-seeking and medical pluralism among Dar es Salaam's urban poor. Globalization and Health 6: 8 doi:10.1186/1744-8603-6-8.
5. Ziraba A, Fotso J, Ochako R, (2009) Overweight and obesity in urban Africa: A problem of the rich or the poor? BMC Public Health 9: 465 doi:10.1186/1471-2458-9-465.
6. Geerlings SE, Hoepelman AIM, (1999) Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunology & Medical Microbiology 26: 259-265 doi:10.1111/j.1574-695X.1999.tb01397.x.
7. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW, (1999) Infections in Patients with Diabetes Mellitus. N Engl J Med 341: 1906-1912 doi:10.1056/NEJM199912163412507.
8. Muller LMAJ, Gorter KJ, Hak E, Goudzwaard WL, Schellevis FG, et al. (2005) Increased Risk of Common Infections in Patients with Type 1 and Type 2 Diabetes Mellitus. Clinical Infectious Diseases 41: 281-288 doi:10.1086/431587.
9. Calvet HM, Yoshikawa TT, (2001) Infections in diabetes. Infect Dis Clin North Am 15: 407-421 viii.
10. Pozzilli P, Leslie RD, (1994) Infections and diabetes: mechanisms and prospects for prevention. Diabet Med 11: 935-941.
11. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, et al. (1997) Impaired leucocyte functions in diabetic patients. Diabet Med 14: 29-34 doi:10.1002/%28SICI%291096-9136%28199701%2914:1%3C29::AID-DIA300%3E3.0.CO;2-V/abstract.
12. Beran D, Yudkin JS, (2006) Diabetes care in sub-Saharan Africa. The Lancet 368: 1689-1695 doi:10.1016/S0140-6736(06)69704-3.
13. Lönnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, et al. (2010) Tuberculosis control and elimination 2010-50: cure, care, and social development. The Lancet 375: 1814-1829 doi:10.1016/S0140-6736(10)60483-7.
14. Harries AD, Murray MB, Jeon CY, Ottmani S-E, Lonnroth K, et al. (2010) Defining the research agenda to reduce the joint burden of disease from Diabetes mellitus and Tuberculosis. Tropical Medicine & International Health 15: 659-663 doi:10.1111/j.1365-3156.2010.02523.x.
15. WHO {pipe} Global tuberculosis control: a short update to the 2009 report (2009) Available: http://www.who.int/tb/publications/global_report/2009/update/en/index.html. Accessed 2010 May 5.
16. Range N, Magnussen P, Mugomela A, Malenganisho W, Changalucha J, et al. (2007) HIV and parasitic co-infections in tuberculosis patients: a cross-sectional study in Mwanza, Tanzania. Ann Trop Med Parasitol 101: 343-351 doi:10.1179/136485907X176373.
17. Hallett TB, Stover J, Mishra V, Ghys PD, Gregson S, et al. (2010) Estimates of HIV incidence from household-based prevalence surveys. AIDS 24: 147-152 doi:10.1097/QAD.0b013e32833062dc.
18. WHO {pipe} Treatment of Tuberculosis: guidelines for national programmes (2009) Available: http://www.who.int/tb/publications/tb_treatmentguidelines/en/index.html. Accessed 1 Mar 2010.
19. Praygod G, Range N, Faurholt-Jepsen D, Jeremiah K, Faurholt-Jepsen M, et al. (2011) Daily Multi-Micronutrient Supplementation during Tuberculosis Treatment Increases Weight and Grip Strength among HIV-Uninfected but Not HIV-Infected Patients in Mwanza, Tanzania. J Nutr 141: 685-691 doi:10.3945/jn.110.131672.
20. Praygod G, Range N, Faurholt-Jepsen D, Jeremiah K, Faurholt-Jepsen M, et al. The effect of energy-protein supplementation on weight, body composition, and handgrip strength among pulmonary tuberculosis HIV-co-infected patients: randomised controlled trial in Mwanza, BJN ((accepted)).
21. Clyne B, Olshaker JS, (1999) The C-reactive protein. Journal of Emergency Medicine 17: 1019-1025 doi:10.1016/S0736-4679(99)00135-3.
22. Dati F, Schumann G, Thomas L, Aguzzi F, Baudner S, et al. (1996) Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470). International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists. Eur J Clin Chem Clin Biochem 34: 517-520.
23. WHO, (2006) WHO {pipe} Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. p. Available: http://www.who.int/diabetes/publications/en/. Accessed 2009 Mar 12.
24. PrayGod G, Range N, Faurholt-Jepsen D, Jeremiah K, Faurholt-Jepsen M, et al. (2010) Weight, body composition and handgrip strength among pulmonary tuberculosis patients: a matched cross-sectional study in Mwanza, Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene In Press, Corrected Proof doi:10.1016/j.trstmh.2010.11.009.
25. Kuhnlein H, Receveur O, (2003) Dietary Change and Traditional Food Systems of Indigenous Peoples. Available: http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.nu.16.070196.002221. Accessed 2008 Dec 3.
26. Jeon CY, Murray MB, (2008) Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 5: e152 doi:PMC2459204.
27. Dooley KE, Chaisson RE, (2009) Tuberculosis and diabetes mellitus: convergence of two epidemics. The Lancet Infectious Diseases 9: 737-746 doi:10.1016/S1473-3099(09)70282-8.
28. Young F, Critchley JA, Johnstone LK, Unwin NC, (2009) A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and Diabetes Mellitus, HIV and Metabolic Syndrome, and the impact of globalization. Global Health 5: 9 doi:10.1186/1744-8603-5-9.
29. Mugusi F, Swai AB, Alberti KG, McLarty DG, (1990) Increased prevalence of diabetes mellitus in patients with pulmonary tuberculosis in Tanzania. Tubercle 71: 271-6 doi:2267680.
30. Gearhart MM, Parbhoo SK, (2006) Hyperglycemia in the critically ill patient. AACN Clin Issues 17: 50-55.
31. Friis H, Gomo E, Mashange W, Nyazema N, Kostel P, et al. (2009) The acute phase response to parturition: a cross-sectional study in Zimbabwe. Afr J Reprod Health 13: 61-68.
32. Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, et al. (1999) Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study. The Lancet 353: 2093-2099 doi:16/S0140-6736(98)08468-2.
33. Moutschen MP, Scheen AJ, Lefebvre PJ, (1992) Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab 18: 187-201.
34. Jeon CY, Harries AD, Baker MA, Hart JE, Kapur A, et al. (2010) Bi-directional screening for tuberculosis and diabetes: a systematic review. Trop. Med. Int. Health 15: 1300-1314 doi:10.1111/j.1365-3156.2010.02632.x.